Psychiatry · Substance Use Disorders (Alcohol, Opioids, Other Substances)

A 28-year-old heroin-dependent man is being considered for opioid substitution therapy (OST). He has previously failed three detoxification attempts. Which agent used in OST acts as a partial agonist at the mu-opioid receptor and reduces illicit opioid use with better safety profile than methadone in overdose?

  • A Naltrexone
  • B Naloxone
  • C Loperamide
  • D Buprenorphine
Correct answer: D. Buprenorphine

Explanation

Buprenorphine is a partial agonist at the mu-opioid receptor and an antagonist at the kappa-opioid receptor. Its partial agonism means it has a 'ceiling effect' on respiratory depression, making it significantly safer in overdose than full agonists like methadone. It is sublingual and highly effective for opioid substitution therapy (OST). Buprenorphine/naloxone combination (Suboxone) is preferred over buprenorphine alone to deter diversion/intravenous misuse (naloxone precipitates withdrawal if injected). Naltrexone is an opioid antagonist used for relapse prevention after detoxification, not for substitution therapy.

Reference: Kaplan & Sadock's Synopsis of Psychiatry, 11th ed.

High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP

Written and medically reviewed by the StethoPrep medical team.

Sponsored

Want to test yourself?

Create a free account for timed mock tests, mistake tracking, and FSRS spaced-repetition revision across 23,000+ MCQs.

Start free → Log in

More Substance Use Disorders (Alcohol, Opioids, Other Substances) MCQs

See all Substance Use Disorders (Alcohol, Opioids, Other Substances) MCQs →